BOT 2.56% 40.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-9086

  1. 3,112 Posts.
    lightbulb Created with Sketch. 1589
    @FAnotTA What anns have I been reading? all of them. But this is from the latest and the most up-to-date and the bit you need to take notice from....From the FDA approves SOFDRA ann...(and the same para is in the capital raising ann)

    "An early patient experience program is planned to be launched by the Company in Q3 CY2024 to
    enable highly qualified patients to gain early access to Sofdra. These patients will be guided through
    the telemedicine and payer reimbursement process to be the first commercial users of the product
    Broader launch of Sofdra is expected to follow in early Q4 CY2024 and Botanix expects to receive first
    revenues from sales in Q4 CY2024."


    What is this saying, do you think?
    Last edited by bavarian1975: 06/07/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.